• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

John Snow Labs Launches Automated Testing for Responsible AI

by Syed Hamza Sohail 07/25/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– John Snow Labs, the AI for healthcare company, today announced the release of Automated Responsible AI Testing Capabilities in the Generative AI Lab.

– This is a first-of-its-kind no-code tool to test and evaluate the safety and efficacy of custom language models. It enables non-technical domain experts to define, run, and share test suites for AI model bias, fairness, robustness, and accuracy.

Comprehensive Testing Solutions for AI in Healthcare and Life Sciences

John Snow Labs, a leading AI company for healthcare, provides advanced software, models, and data to enhance AI application in healthcare and life science organizations. The company is renowned for developing Spark NLP, Healthcare NLP, the Healthcare GPT LLM, the Generative AI Lab No-Code Platform, and the Medical Chatbot. Their award-winning medical AI software supports top pharmaceuticals, academic medical centers, and health technology companies globally.

John Snow Labs’ capabilities are built on the open-source LangTest library, which includes over 100 test types for various aspects of Responsible AI, such as bias, security, toxicity, and political leaning. LangTest leverages Generative AI to automatically generate test cases, allowing for a comprehensive set of tests to be produced in minutes rather than weeks. Designed specifically for testing custom AI models, LangTest addresses scenarios not covered by general-purpose benchmarks and leaderboards.

Recent US legislation has made comprehensive testing essential for companies aiming to release new AI-based products and services:

– The ACA Section 1557 Final Rule, effective June 2024, prohibits discrimination in medical AI algorithms based on race, color, national origin, gender, age, or disability.

– The HTI-1 Final Rule on transparency in medical decision support systems mandates companies to demonstrate how their models are trained and tested.

– The American Bar Association Guidelines require extensive internal and third-party audits before AI deployments, responding to lawsuits against companies providing models that match job descriptions with candidates’ resumes.

There is an urgent need for comprehensive testing solutions for Large Language Models (LLMs). Many domain experts lack the technical expertise to perform such testing, and many data scientists lack the domain expertise to build comprehensive, industry-specific models. The Generative AI Lab addresses this gap by enabling domain experts to create, edit, and understand model testing without the need for a data scientist. The tool incorporates best practices, including versioning, sharing, and automated test execution for every new model.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |